Security National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2K Hold
500
0.01% 253
2026
Q1
$40K Hold
500
0.01% 255
2025
Q4
$42.6K Hold
500
0.01% 247
2025
Q3
$38.9K Hold
500
0.01% 258
2025
Q2
$39.1K Hold
500
0.01% 232
2025
Q1
$36.2K Hold
500
0.01% 232
2024
Q4
$37K Hold
500
0.01% 228
2024
Q3
$33K Hold
500
﹤0.01% 218
2024
Q2
$46.2K Sell
500
-155
-24% -$13.7K 0.01% 199
2024
Q1
$62.6K Hold
655
0.01% 177
2023
Q4
$49.9K Buy
+655
New +$45.6K 0.01% 195

Other funds holding EW

Security National Bank's EW Position: Q2 2026 in Review

Security National Bank held its Edwards Lifesciences (EW) position steady in Q2 2026 at 500 shares worth $45.2K. The position accounts for 0.01% of the portfolio, ranked #253.

Security National Bank first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $62.6K in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Security National Bank held 500 shares of Edwards Lifesciences worth $45.2K as of Q2 2026.
  • Security National Bank left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Security National Bank's portfolio in Q2 2026, its #253 holding.
  • Security National Bank first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Security National Bank's Edwards Lifesciences position peaked at $62.6K in Q1 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Security National Bank's 13F filing for Q2 2026, filed 15 Jul 2026.